CareCloud Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

CareCloud wird ein Gewinn- und Umsatzwachstum von 112.3% bzw. 15.6% pro Jahr prognostiziert, während der Gewinn pro Aktie um 112.8% pro Jahr wachsen soll.

Wichtige Informationen

112.3%

Wachstumsrate der Gewinne

112.8%

EPS-Wachstumsrate

Healthcare Services Gewinnwachstum	32.5%
Wachstumsrate der Einnahmen	15.6%
Zukünftige Eigenkapitalrendite	n/a
Analystenabdeckung	Low
Zuletzt aktualisiert	21 Jan 2025

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

The Market Doesn't Like What It Sees From CareCloud, Inc.'s (NASDAQ:CCLD) Revenues Yet As Shares Tumble 25%

Jan 18

CareCloud, Inc. (NASDAQ:CCLD) Shares Fly 34% But Investors Aren't Buying For Growth

Nov 13

We Think CareCloud (NASDAQ:CCLD) Has A Fair Chunk Of Debt

Oct 07

CareCloud, Inc. (NASDAQ:CCLD) Shares Fly 25% But Investors Aren't Buying For Growth

Aug 31

CareCloud, Inc. (NASDAQ:CCLD) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough

Jul 13

We Think CareCloud (NASDAQ:CCLD) Has A Fair Chunk Of Debt

Jun 27

CareCloud, Inc. (NASDAQ:CCLD) Held Back By Insufficient Growth Even After Shares Climb 158%

May 22

CareCloud, Inc. (NASDAQ:CCLD) Shares Could Be 42% Below Their Intrinsic Value Estimate

Mar 22

The Market Doesn't Like What It Sees From CareCloud, Inc.'s (NASDAQ:CCLD) Revenues Yet As Shares Tumble 27%

Mar 22

Little Excitement Around CareCloud, Inc.'s (NASDAQ:CCLD) Revenues As Shares Take 25% Pounding

Feb 02

Is CareCloud (NASDAQ:CCLD) Using Too Much Debt?

Jan 30

CareCloud, Inc.'s (NASDAQ:CCLD) 31% Dip In Price Shows Sentiment Is Matching Revenues

Dec 19

CareCloud, Inc. (NASDAQ:CCLD) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

May 06

There's Been No Shortage Of Growth Recently For CareCloud's (NASDAQ:CCLD) Returns On Capital

Mar 05

CareCloud (NASDAQ:MTBC) Is Looking To Continue Growing Its Returns On Capital

Aug 20

These 4 Measures Indicate That CareCloud (NASDAQ:MTBC) Is Using Debt Safely

Jul 23

CareCloud (NASDAQ:MTBC) Shareholders Will Want The ROCE Trajectory To Continue

May 12

MTBC Has Dropped A 'Bomb' On MTBCP, Consequently Creating A 'Game-Changer' Event For Both

Jan 28

CareCloud EPS beats by $0.03, beats on revenue

May 06

Gewinn- und Umsatzwachstumsprognosen

NasdaqGM:CCLD - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2027	180	N/A	N/A	N/A	1
12/31/2026	126	-4	N/A	23	3
12/31/2025	112	-3	21	27	5
12/31/2024	111	-5	15	21	5
9/30/2024	111	-52	12	19	N/A
6/30/2024	112	-58	7	16	N/A
3/31/2024	113	-62	8	19	N/A
12/31/2023	117	-64	4	15	N/A
9/30/2023	121	-20	6	18	N/A
6/30/2023	126	-16	8	20	N/A
3/31/2023	133	-12	7	19	N/A
12/31/2022	139	-10	9	21	N/A
9/30/2022	144	-7	9	21	N/A
6/30/2022	148	-6	8	19	N/A
3/31/2022	145	-9	4	15	N/A
12/31/2021	140	-11	3	13	N/A
9/30/2021	134	-15	1	11	N/A
6/30/2021	128	-18	-5	4	N/A
3/31/2021	113	-23	-4	4	N/A
12/31/2020	105	-23	-9	-1	N/A
9/30/2020	89	-21	-8	-1	N/A
6/30/2020	74	-16	-4	1	N/A
3/31/2020	71	-11	-1	3	N/A
12/31/2019	64	-7	5	8	N/A
9/30/2019	65	-8	5	7	N/A
6/30/2019	65	-9	7	8	N/A
3/31/2019	57	-8	6	7	N/A
12/31/2018	51	-7	6	7	N/A
9/30/2018	42	-6	5	6	N/A
6/30/2018	33	-4	N/A	3	N/A
3/31/2018	32	-5	N/A	2	N/A
12/31/2017	32	-8	N/A	0	N/A
9/30/2017	32	-11	N/A	-2	N/A
6/30/2017	30	-11	N/A	-1	N/A
3/31/2017	28	-10	N/A	-1	N/A
12/31/2016	24	-10	N/A	-1	N/A
9/30/2016	21	-6	N/A	0	N/A
6/30/2016	21	-6	N/A	-1	N/A
3/31/2016	22	-6	N/A	-1	N/A
12/31/2015	23	-5	N/A	-2	N/A
9/30/2015	25	-5	N/A	-3	N/A
6/30/2015	25	-6	N/A	-4	N/A
3/31/2015	22	-5	N/A	-4	N/A
12/31/2014	18	-5	N/A	-3	N/A
9/30/2014	14	-3	N/A	-2	N/A
6/30/2014	11	-1	N/A	1	N/A
3/31/2014	11	-1	N/A	1	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: CCLD wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Ertrag vs. Markt: CCLD wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Hohe Wachstumserträge: CCLD wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Einnahmen vs. Markt: CCLDDie Einnahmen des Unternehmens (15.6% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (8.8% pro Jahr).

Hohe Wachstumseinnahmen: CCLDDie Einnahmen des Unternehmens (15.6% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von CCLD in 3 Jahren voraussichtlich hoch sein wird

Wachstumsunternehmen entdecken

Unternehmensanalyse und Finanzdaten Status

Daten	Zuletzt aktualisiert (UTC-Zeit)
Unternehmensanalyse	2025/01/31 09:20
Aktienkurs zum Tagesende	2025/01/31 00:00
Gewinne	2024/09/30
Jährliche Einnahmen	2023/12/31

Datenquellen

Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.

Paket	Daten	Zeitrahmen	Beispiel US-Quelle ^*
Finanzdaten des Unternehmens	10 Jahre	Gewinn- und Verlustrechnung Kapitalflussrechnung Bilanz	SEC-Formular 10-K SEC-Formular 10-Q
Konsensschätzungen der Analysten	+3 Jahre	Finanzielle Vorausschau Kursziele der Analysten	Analysten Research Berichte Blue Matrix
Marktpreise	30 Jahre	Aktienkurse Dividenden, Splits und Aktionen	ICE-Marktdaten SEC-Formular S-1
Eigentümerschaft	10 Jahre	Top-Aktionäre Insiderhandel	SEC-Formular 4 SEC-Formular 13D
Verwaltung	10 Jahre	Das Führungsteam Direktorium	SEC-Formular 10-K SEC-Formular DEF 14A
Wichtige Entwicklungen	10 Jahre	Ankündigungen des Unternehmens	SEC-Formular 8-K

^* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige Formulare und Quellen verwendet.

Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie hier mehr.

Analysemodell und Schneeflocke

Einzelheiten zum Analysemodell, das zur Erstellung dieses Berichts verwendet wurde, finden Sie auf unserer Github-Seite. Wir haben auch Anleitungen zur Verwendung unserer Berichte und Tutorials auf Youtube.

Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.

Metriken für Industrie und Sektor

Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf .

Analysten-Quellen

CareCloud, Inc. wird von 10 Analysten beobachtet. 5 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.

Analyst	Einrichtung
Michael Hickey	Benchmark Company
William Sutherland	Benchmark Company
Marc Wiesenberger	B. Riley Securities, Inc.

CareCloud Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

CareCloud, Inc. Reaffirms Earnings Guidance for the Full Year 2024

Consensus EPS estimates upgraded to US$0.037 loss

Price target increased by 7.3% to US$3.68

CareCloud, Inc. Reiterates Revenue Guidance for the Year 2024

Consensus EPS estimates upgraded to US$0.77 loss, revenue downgraded

CareCloud, Inc. Reiterates Revenue Guidance for the Fiscal Year Ending December 31, 2023

Recent updates

The Market Doesn't Like What It Sees From CareCloud, Inc.'s (NASDAQ:CCLD) Revenues Yet As Shares Tumble 25%

CareCloud, Inc. Announces Management Changes, Effective January 1, 2025

CareCloud, Inc. Reaffirms Earnings Guidance for the Full Year 2024

CareCloud, Inc. (NASDAQ:CCLD) Shares Fly 34% But Investors Aren't Buying For Growth

CareCloud, Inc. to Report Q3, 2024 Results on Nov 12, 2024

We Think CareCloud (NASDAQ:CCLD) Has A Fair Chunk Of Debt

CareCloud, Inc. (NASDAQ:CCLD) Shares Fly 25% But Investors Aren't Buying For Growth

CareCloud, Inc. to Report Q2, 2024 Results on Aug 13, 2024

CareCloud, Inc. (NASDAQ:CCLD) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough

We Think CareCloud (NASDAQ:CCLD) Has A Fair Chunk Of Debt

CareCloud, Inc. (NASDAQ:CCLD) Held Back By Insufficient Growth Even After Shares Climb 158%

CareCloud, Inc Promotes Crystal Williams to Chief Operating Officer

Consensus EPS estimates upgraded to US$0.037 loss

Price target increased by 7.3% to US$3.68

CareCloud, Inc. Reiterates Revenue Guidance for the Year 2024

CareCloud, Inc. to Report Q1, 2024 Results on May 14, 2024

CareCloud, Inc., Annual General Meeting, Jun 17, 2024

Consensus EPS estimates upgraded to US$0.77 loss, revenue downgraded

CareCloud, Inc. (NASDAQ:CCLD) Shares Could Be 42% Below Their Intrinsic Value Estimate

The Market Doesn't Like What It Sees From CareCloud, Inc.'s (NASDAQ:CCLD) Revenues Yet As Shares Tumble 27%

Full year 2023 earnings released: US$4.11 loss per share (vs US$0.67 loss in FY 2022)

CareCloud, Inc. to Report Q4, 2023 Results on Mar 21, 2024

Little Excitement Around CareCloud, Inc.'s (NASDAQ:CCLD) Revenues As Shares Take 25% Pounding

Is CareCloud (NASDAQ:CCLD) Using Too Much Debt?

CareCloud, Inc. Announces Chief Financial Officer Changes

CareCloud Takes Center Stage at The Arab Health Exhibition and Congress 2024

Founder & Executive Chairman recently bought US$645k worth of stock

CareCloud, Inc.'s (NASDAQ:CCLD) 31% Dip In Price Shows Sentiment Is Matching Revenues

Carecloud, Inc. Appoints Justin Pierce as Its Chief Sales Officer

Independent Director recently bought US$97k worth of stock

CareCloud, Inc. Reiterates Revenue Guidance for the Fiscal Year Ending December 31, 2023

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

CareCloud, Inc. to Report Q3, 2023 Results on Nov 02, 2023

CareCloud, Inc. Appoints Bill Korn as Board of Directors

Is CareCloud (NASDAQ:CCLD) A Risky Investment?

Carecloud, Inc. Reaffirms Revenue Guidance for the Fiscal Year 2023

New minor risk - Share price stability

Consensus revenue estimates fall by 15%

Things Look Grim For CareCloud, Inc. (NASDAQ:CCLD) After Today's Downgrade

Price target decreased by 32% to US$6.28

CareCloud, Inc. Provides Revenue Guidance for the Fiscal Year Ending December 31, 2023

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

There's No Escaping CareCloud, Inc.'s (NASDAQ:CCLD) Muted Revenues

CareCloud, Inc. to Report Q2, 2023 Results on Aug 03, 2023

CareCloud, Inc. Appoints Larry Steenvoorden as Chief Financial Officer

No longer forecast to breakeven

CareCloud Strengthens Leadership Team with Key Transitions

CareCloud, Inc. (NASDAQ:CCLD) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

First quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Carecloud, Inc. Reiterates Revenue Guidance for the Fiscal Year Ending December 31, 2023

There's Been No Shortage Of Growth Recently For CareCloud's (NASDAQ:CCLD) Returns On Capital

Full year 2022 earnings: EPS misses analyst expectations

CareCloud, Inc. to Report Q4, 2022 Results on Mar 02, 2023

CareCloud, Inc. to Unveil Innovative EHR Therapy Platform At American Physical Therapy Association Meeting

CareCloud, Inc. Charts Now Certified for Interoperability According to ONC Standards

CareCloud, Inc. Updates Revenue Guidance for the Year 2022 and 2023

Forecast to breakeven in 2025

Price target decreased to US$8.92

Insufficient new directors

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

CareCloud, Inc. Reiterates Earnings Guidance for the Year 2022

CareCloud, Inc. to Report Q3, 2022 Results on Nov 03, 2022

CareCloud, Inc. Announces the Launch of Its Remote Patient Monitoring Solution

CareCloud, Inc. Deploys Its CareCloud Wellness to Bring Providers Next Generation Chronic Care Management Services

CareCloud (NASDAQ:MTBC) Is Looking To Continue Growing Its Returns On Capital

Consensus EPS estimates fall by 12%

Second quarter 2022 earnings: EPS exceeds analyst expectations

CareCloud, Inc. Provides Revenue Guidance for Full Year 2022

Price target decreased to US$12.58